AST SpaceMobile Delays Service Launch to 2027, Eyes 'Acquisitions' The Starlink Mobile rival signals it's pursuing partnerships or acquisitions to bolster its satellite launch capabilities, following ...

AST SpaceMobile said late July 15 that it is raising up to $1.15 billion gross via debt later eligible to be turned into stock or cash, in part for potential acquisitions or partnerships. The ...

AST is building and deploying a satellite constellation designed to deliver cellular and broadband coverage through the networks of established telecom operators such as Verizon, AT&T, and Vodafone.

AST’s carrier-first model could help it scale up its business without competing directly with telecom giants. The bull case for the stock hinges on the company winning massive subscriber adoption and ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

AST SpaceMobile suffered a set-back in May when a Blue Origin New Glenn rocket failed to reach its correct orbit and the AST satellite was lost and eventually deorbited. AST is hoping for a more ...

AST SpaceMobile plans to send three more BlueBird satellites into orbit aboard a SpaceX Falcon 9 rocket in mid-June, a flight that would expand its constellation to ten spacecraft designed to deliver ...

ANCHORAGE, Alaska (KTUU) - A man is dead after officer-involved shooting in Utqiaġvik Saturday, the North Slope Borough said. “Officers with the North Slope Borough Police Department (NSBPD) were ...

Space stocks are back in rally mode at midday Friday, with the sector’s three highest-profile pure plays moving sharply higher in unison. AST SpaceMobile (NASDAQ:ASTS) stock is up 7%, Rocket Lab ...

AST SpaceMobile (NASDAQ:ASTS) has been continuously surging. A satellite unfolds in orbit, a regulator signs off, a carrier signs a contract, and investors keep going back to the buy button. The stock ...

Clinical microbiology laboratories are under increasing pressure to deliver accurate, clinically meaningful antimicrobial susceptibility results while managing staffing constraints, rising test ...